Nonprescription bronchodilator medication use in asthma

Chest

Volumn 112, Issue 4, 1997, Pages 987-993

  Kuschner, Ware G ^a,b,d,e   Hankinson, Todd C ^c   Wong, Hofer H ^a   Blanc, Paul D ^a,b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MIDDLEBURY COLLEGE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f NONE   (United States)

Author keywords

Asthma; Bronchodilator; Nonprescription; OTC; PFT

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; EPHEDRINE; NON PRESCRIPTION DRUG; SALBUTAMOL; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH CARE ACCESS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF MEDICATION; SPIROMETRY; TREATMENT OUTCOME;

EID: 0030846010     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.4.987     Document Type: Article

References (23)

1. Bahner DR, Frenia ML, Augenstein WL. Theophylline toxicity from an over-the-counter preparation. J Emerg Med 1993; 11:427-30
2. Stewart MJ, Fraser DM, Boon N. Dilated cardiomyopathy associated with chrome overuse of an adrenaline inhaler. Br Heart J 1992; 68:221-22
3. Keyes WG. Theophylline toxicity caused by an over-the-counter antiasthmatic preparation. Clin Pediatr 1987; 26:630
4. Gardner RA, Hansen AE, Ewing PL, et al. Unexpected fatality in a child from accidental consumption of antiasthmatic preparation containing ephedrine, theophylline and phenobarbital. Tex State J Med 1950; 46:516-20
5. Loria RC, Wedner HJ. Facial swelling secondary to inhaled bronchodilator abuse: catecholamine-induced sialadenosis. Ann Allergy 1989; 62:289-93
6. Centers for Disease Control. Adverse events associated with ephedrine-containing products Texas, December 1993-September 1995. MMWR 1996; 45:689-93
7. Litovitz TL, Felberg L, White S, et al. 1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1996; 14:487-537
8. Litovitz TL, Felberg L, Soloway RA, et al. 1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1995; 13:551-97
9. National Asthma Education Program. Guidelines for the diagnosis and management of asthma: publication No. 91-3042. Bethesda, Md: National Institutes of Health, 1991
10. British Thoracic Society. Guidelines for management of asthma in adults: chronic persistent asthma. BMJ 1990; 301:651-53
11. Rea HH, Scragg R, Jackson R, et al. A case control of deaths from asthma. Thorax 1986; 41:833-39
12. Johnson AJ, Nunn AJ, Somner AR, et al. Circumstances of death from asthma. BMJ 1984; 288:1870-72
13. Ruffin RE, Latimer KM, Schembri DA. Longitudinal study of near fatal asthma. Chest 1991; 99:77-83
14. Hartert TV, Windom HH, Peebles RS, et al. Inadequate outpatient medical therapy in patients with asthma admitted to two urban hospitals. Am J Med 1996; 100:386-94
15. Kallenbach JM, Frankel AH, Lapinsky SE, et al. Determinants of near fatality in acute severe asthma. Am J Med 1993; 95:265-72
16. McFadden ER, Gilbert IA. Asthma. N Engl J Med 1992; 27:1928-37
17. Henry DA, Sutherland D, Francis L, et al. The use of non-prescription salbutamol inhalers by asthmatic patients in the Hunter Valley, New South Wales. Med J Aust 1989; 150:445-49
18. 2 agonist inhalers and undertreatment of asthma. BMJ 1993; 306:1514-18
19. Comino EJ, Henry RL, Mitchell CA, et al. Asthma management and mode of acquisition of inhaled bronchodilators. Aust NZ J Med 1995; 25:496-502
20. Blanc PD, Cisternas M, Smith S, et al. Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists. Chest 1996; 109:688-96
21. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123:659-64
22. Moscato G, Godnic-Cvar J, Maestrelli P. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Eur Respir J 1995; 8:1605-10
23. Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994; 330:1329-34